Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

3.7%

1 terminated/withdrawn out of 27 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

48%

13 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

11 recruiting

Enrollment Performance

Analytics

Phase 3

11(52.4%)

N/A

4(19.0%)

Phase 4

2(9.5%)

Phase 1

2(9.5%)

Phase 2

2(9.5%)

21Total

Phase 3(11)

N/A(4)

Phase 4(2)

Phase 1(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials

NCT05357846Phase 3Recruiting

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

Role: collaborator

NCT07095023Not ApplicableRecruiting

Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer

Role: collaborator

NCT07311772Phase 3Recruiting

Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid

Role: collaborator

NCT07188584Phase 3Recruiting

Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer

Role: collaborator

NCT07201337Phase 3Recruiting

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

Role: collaborator

NCT04555226Not ApplicableRecruiting

The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)

Role: collaborator

NCT07104604Phase 1Recruiting

Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Toripalimab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement

Role: lead

NCT07020468Phase 4Active Not Recruiting

Neoadjuvant Therapy （NALIRIFOX） for Locally Advanced Colon and Upper Rectal Cancer

Role: lead

NCT06713681Recruiting

Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery

Role: collaborator

NCT06510738Not Yet Recruiting

Prediction of Non-sentinel Lymph Node Metastatic Status of Breast Cancer Based on Pathology-MRI Images

Role: collaborator

NCT06486155Not Yet Recruiting

Evaluation of Axillary Lymph Node Metastasis Status of Breast Cancer Based on Pathological Images and Virtual Staining

Role: collaborator

NCT04991493Phase 4Recruiting

Effect of Tramadol on Postoperative Sore Throat After General Anesthesia

Role: lead

NCT04923802Terminated

Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)

Role: collaborator

NCT06186739Not ApplicableUnknown

Rehabilitation Training Participated by Caregivers in Ischemic Stroke: a Randomized Controlled Trial to Test the Effect of Home-based Rehabilitation Intervention on Physical Function.

Role: collaborator

NCT06012318Unknown

Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)

Role: collaborator

NCT05984342Phase 1Recruiting

Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma

Role: lead

NCT05980715Phase 3Recruiting

PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy

Role: collaborator

NCT02288195Phase 3Unknown

CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients

Role: collaborator

NCT02460419Phase 3Completed

Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma

Role: collaborator

NCT03373058Phase 3Unknown

Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery

Role: collaborator